Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients

Bibliography

• Holstein A, Plaschke A, Egberts E-H. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 2001;17:467-73
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Karter AJ, Yaffe K, Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
   PubMed Web of Science ®Google Scholar
• Evans JM, Ogston SA, Emslie-Smith A, Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 2006;49:930-6
   PubMed Web of Science ®Google Scholar
• Tzoulaki I, Molokhia M, Curcin V, Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ 2009;339:b4731
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009;52:1176-80
   Google Scholar
• Libby G, Donnelly LA, Donnan PT, New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009;32:1620-5
   PubMed Web of Science ®Google Scholar
• Holstein A, Plaschke A, Vogel M-Y, Egberts E-H. Prehospital management of diabetic emergencies – a population-based intervention study. Acta Anaesthesiol Scand 2003;47:610-5
   PubMed Web of Science ®Google Scholar
• Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-100
   PubMed Web of Science ®Google Scholar
• WHO. BMI Classification. Available from:: http://apps.who.int/bmi/index.jsp
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. Mini-mental state (a practical method for grading the state of patients for the clinician). J Psychiatr Res 1975;12:189-98
   PubMed Web of Science ®Google Scholar
• Leese GP, Wang J, Broomhall J, for the DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. Diabetes Care 2003;26:1176-80
   PubMed Web of Science ®Google Scholar
• Asplund K, Wiholm B-E, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983;24:412-7
   PubMed Web of Science ®Google Scholar
• Girardin E, Vial T, Pham E, Evreux JC. Hypoglycemia induced by oral hypoglycemic agents. Records of the French Regional Pharmacovigilance Centers 1985-1990. Ann Med Interne 1992;143:11-7
   PubMedGoogle Scholar
• Greco D, Oisciotta M, Gambina F, Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes 2010. [Epub ahead of print]
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-61
   PubMedGoogle Scholar
• Abbatecola AM, Paolisso G. Diabetes care targets in older persons. Diabetes Res Clin Pract 2009;86(Suppl 1):S35-40
   PubMedGoogle Scholar
• Vischer UM, Bauduceau B, Bourdel-Marchasson I, A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes Metab 2009;35:168-77
   PubMed Web of Science ®Google Scholar
• Bremer J, Jauch-Chara K, Hallschmid M, Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009;32:1513-37
   PubMed Web of Science ®Google Scholar
• Thomson TFJ, Masson EA, Leeming JT. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing 1991;20:404-6
   PubMed Web of Science ®Google Scholar
• European Diabetes Working Party for Older People: Clinical Guidelines for Type 2 Diabetes Mellitus, 2004. Available from: http://www.eugms.org/index.php?pid=30
   Google Scholar
• Abaterusso C, Lupo A, Ortalda V, Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1185-94
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Byington RP, Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
   PubMed Web of Science ®Google Scholar
• Currie CJ, Peters JR, Tynan A, Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-9
   PubMed Web of Science ®Google Scholar
• Thomas C, Thomas L. Renal failure – measuring the glomerular filtration rate. Dtsch Arztebl Int 2009;106(51-52):849-54
   PubMed Web of Science ®Google Scholar
• Niemi M, Cascorbi I, Timm R, Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Clin Pharmacol Ther 2002;72:326-32
   PubMed Web of Science ®Google Scholar
• Holstein A, Beil W. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions. Expert Opin Drug Metab Toxicol 2009;5:225-41
   PubMed Web of Science ®Google Scholar
• Amiel SA, Dixon T, Mann R, Hypoglycaemia in type 2 diabetes. Diab Med 2008;25:245-54
   PubMed Web of Science ®Google Scholar
• Mengel K. Antidiabetika. In: Schwabe U, Paffrath D, editors, Arzneimittelverordnungs-Report 2009. Springer Verlag, Heidelberg; 2009. p. 327-29
   Google Scholar
• Holstein A, Plaschke A, Egberts E-H. Incidence and costs of severe hypoglycemia. Diabetes Care 2002;25:2109-10
   PubMed Web of Science ®Google Scholar
• Available from: http://www.deutsche-diabetes-gesellschaft.de. Stellungnahme Blutzuckerteststreifen bei Patienten mit Diabetes mellitus Typ 2
   Google Scholar
• Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-705
   PubMed Web of Science ®Google Scholar
• Pratley RE, Rosenstock J, Pi-Sunyer FX, Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy. Diabetes Care 2007;30:3017-22
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Fonseca V, Zinman B, Fifty-two-week efficacy and safety of vildagliptine vs, glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diab Obes Metab 2009;11:157-66
   PubMed Web of Science ®Google Scholar
• Schweizer A, Dejager S, Bosi E. Comparison of vildagliptine and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diab Obes Metab 2009;11:804-12
   PubMed Web of Science ®Google Scholar